Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in CRDF — Cardiff Oncology, Inc.

CIK 73124 CHICAGO, IL
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$198,736
-$600,254 QoQ
Shares Held
152,875
-69.0% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 104 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. CRDF ranks #314 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in CRDF

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $198,736 152,875
2026-03-31 $798,990 493,205
2025-12-31 $1,297,524 461,753
2025-09-30 $1,070,687 519,752
2025-06-30 $2,282,019 724,451
2025-03-31 $1,520,902 484,364
2024-12-31 $1,462,979 337,092
2024-09-30 $826,639 309,603
2024-06-30 $218,543 98,443
2024-03-31 $456,639 85,513
2023-12-31 $105,651 71,386
2023-09-30 $99,226 71,386
2023-06-30 $106,407 72,386
2023-03-31 $116,197 70,423
2022-12-31 $97,137 69,384
2022-09-30 $106,850 69,384
2022-06-30 $146,502 66,592
2022-03-31 $788,286 317,858
2021-12-31 $2,037,875 339,081
2021-09-30 $2,155,881 323,706
2021-06-30 $2,113,668 317,845
2021-03-31 $431,488 46,597
2020-12-31 $800,914 44,520
2020-09-30 $352,153 24,817
2020-06-30 $56,823 11,342